Negi Masaru

Masaru Negi, MD

Specialties:

Maternal & Fetal Medicine
  • Valley Health Provider

Accepting new patients.

Accepted Insurance & Health Plans

About

Masaru Negi, MD, is a double board-certified Maternal Fetal Medicine and Obstetrics and Gynecology (OBGYN) specialist. Dr. Negi completed medical school at Stony Brook University in New York. He went on to complete his OBGYN residency through Yale-New Haven Hospital and Maternal Fetal Medicine fellowship through the Yale School of Medicine in New Haven, Connecticut.

Dr. Negi’s clinical interests include diabetes in pregnancy, preterm birth, and fetal diagnosis, including amniocentesis. His research background explores outcomes related to different models of prenatal care and labor management. Dr. Negi enjoys furthering education and empowering patients in their healthcare journey.

Medical Areas of Interest:

  • Fetal Ultrasound
  • Preterm Birth
  • Genetic Counseling
  • Preconception Counseling
  • Hypertensive Disorders of Pregnancy
  • Diabetes in Pregnancy

Affiliations

  • Shenandoah Valley Maternal Fetal Medicine
  • Winchester Medical Center

Awards

  • Fellow, American College of Obstetricians and Gynecologists
  • Fellow, Society for Maternal-Fetal Medicine

Locations

Education

Board Certification

Maternal Fetal Medicine Obstetrics and Gynecology

Fellowship

Yale School of Medicine Maternal Fetal Medicine

Residency

Yale-New Haven Hospital Obstetrics and Gynecology

Medical School

Stony Brook University School of Medicine Doctor of Medicine

Publications

2022

Risk Factors for Measles Non-Immunity in Rubella-Immune Pregnant Patients

Issue #2022 Mar 15, 2022

  • Author: Kassir E, Holliman K, Negi M, Duong HL, Tandel MD, Herbert L, Lee G, Silverman N, Rao R, Han CS
  • Publisher: American Journal of Perinatology

2021

Favorable Simplified Bishop Score after cervical ripening associated with decreased cesarean birth rate

Issue #2021 Nov 20;4(2):100534, 2021

  • Author: Lee DS, Tandel MD, Kwan L, Francoeur AA, Duong HL, Negi M
  • Publisher: American Journal of Obstetrics & Gynecology MFM

2020

Allopurinol inhibits excess glucose-induced trophoblast IL-1ß and ROS production.
Issue #2020 Jan;159(1):73-80, 2020
  • Author: Negi M, Mulla MJ, Han CS, Abrahams VM
  • Publisher: Reproduction
Gender representation of speakers at the Society for Maternal-Fetal Medicine postgraduate courses: a 20-year review
Issue #2020 Aug;2(3):100131, 2020
  • Author: Mei JY, Negi M, Han CS, Rao R, Krakow D, Afshar Y
  • Publisher: American Journal of Obstetrics & Gynecology MFM
May-Thurner syndrome in pregnancy: a multi-institutional case series and review of the literature
Issue #2020 Nov;2(4):100240, 2020
  • Author: Mei JY, Deshmukh U, Negi M, Campbell K, Paidas MJ, Platt LD, Silverman NS, Han CS
  • Publisher: American Journal of Obstetrics & Gynecology MFM